Shein Steven L, Roth Elizabeth, Pace Elizabeth, Slain Katherine N, Wilson-Costello Deanne
Division of Pediatric Critical Care Medicine, Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States.
Department of Pediatrics, Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States.
J Pediatr Intensive Care. 2020 Sep 18;10(4):282-288. doi: 10.1055/s-0040-1716856. eCollection 2021 Nov.
Bronchiolitis is a common pediatric intensive care unit (PICU) illness and often affects generally healthy children, making it a promising disease in which to study long-term neurodevelopmental outcomes. We previously found that approximately 15% of critical bronchiolitis patients have evidence of post-PICU morbidity using coarse definitions available in administrative data sets. In this study, we measured neurodevelopmental outcomes using four more precise tools. Children who had previously been admitted to our PICU with bronchiolitis were included; those with evidence of developmental delay at PICU admission were excluded. Approximately 1 to 2 years after PICU discharge, the parent of each subject completed two questionnaires (Ages and Stages Questionnaire and Pediatric Evaluation of Disability Inventory Computer Adaptive Test). Each subject also underwent two in-person assessments administered by a certified examiner (Bayley Scales of Infant and Toddler Development, 3rd edition, and the Amiel-Tison neurological assessment). For each domain of each test, a score of > 1 standard deviation below the norm for the subject's age defined "moderate" disability and a score ≥ 2 standard deviations below the norm defined "severe" disability. Eighteen subjects (median ages of 3.7 months at PICU admission and 2.3 years at testing) were enrolled, 17 of whom were supported by high-flow nasal cannula and/or mechanical ventilation. Fifteen children (83%) scored abnormally on ≥ 1test. Eight children (44%) had disabilities in ≥ 3 domains and/or ≥ 1 severe disability identified. Our findings that motor, language, and cognitive disabilities are commonly observed months to years after critical bronchiolitis require larger studies to confirm this finding, assess causality, and identify modifiable risk factors.
细支气管炎是儿科重症监护病房(PICU)常见的疾病,通常影响一般健康的儿童,使其成为研究长期神经发育结局的一个有前景的疾病。我们之前发现,使用行政数据集中可用的粗略定义,约15%的重症细支气管炎患者有PICU后发病的证据。在本研究中,我们使用四种更精确的工具测量神经发育结局。纳入之前因细支气管炎入住我们PICU的儿童;排除在PICU入院时有发育迟缓证据的儿童。在PICU出院后约1至2年,每个受试者的家长完成两份问卷(年龄与发育阶段问卷和残疾儿童评估量表计算机自适应测试)。每个受试者还接受了由一名认证考官进行的两次面对面评估(贝利婴幼儿发展量表第三版和阿米尔 - 蒂松神经学评估)。对于每项测试的每个领域,得分低于该受试者年龄正常标准>1个标准差定义为“中度”残疾,得分低于正常标准≥2个标准差定义为“重度”残疾。共纳入18名受试者(PICU入院时的中位年龄为3.7个月,测试时为2.3岁),其中17名接受了高流量鼻导管和/或机械通气支持。15名儿童(83%)在≥1项测试中得分异常。8名儿童(44%)在≥3个领域存在残疾和/或被确定有≥1项重度残疾。我们的研究结果表明,在重症细支气管炎数月至数年后,运动、语言和认知残疾很常见,这需要更大规模的研究来证实这一发现、评估因果关系并确定可改变的风险因素。